A REAL-WORLD PHARMACOVIGILANCE STUDY USING NATIONAL RUSSIAN DATABASE OF ADVERSE EVENTS OF COVID-19-RELATED DRUGS: FOCUS ON HYDROXYCHLOROQUINE

被引：0
|
作者：
Kolbin, A. [1 ]
Mishinova, S. A. [1 ]
Syraeva, G., I [1 ]
Polushin, Y. S. [1 ]
机构：
[1] First Pavlov State Med Univ St Petersburg, St Petersburg, SPE, Russia
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD91
引用
收藏
页码：S593 / S593
页数：1
相关论文
共 50 条
  • [1] Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database
    Sun, Yu
    Xu, Tao
    Zhu, Suyan
    Xu, Hongbin
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [2] The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
    Wang, Xiaogan
    Chen, Hao
    Han, Shuangshuang
    Li, Lingbo
    Chen, Hongjin
    Yang, Bolin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Fluoroquinolones-related psychiatric adverse events: a real-world retrospective and pharmacovigilance database analysis
    Li, JuanJuan
    Yin, Xiaohong
    Zhao, Yang
    Yang, Xueqin
    Wang, Jing
    Yuan, Ting
    Zheng, Juan
    Tang, Qian
    Wei, Wei
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [4] Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
    Sato, Kenichiro
    Mano, Tatsuo
    Iwata, Atsushi
    Toda, Tatsushi
    BIOSCIENCE TRENDS, 2020, 14 (02) : 139 - 143
  • [5] Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
    Li, Dongxuan
    Gou, Jinghui
    Zhu, Jun
    Zhang, Tongyan
    Liu, Feng
    Zhang, Daojun
    Dai, Liyang
    Li, Wenjun
    Liu, Qinglong
    Qin, Chunmeng
    Du, Qian
    Liu, Songqing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
    Yongfu Song
    Zhuang Wang
    Na Wang
    Xiaofei Xie
    Tieshi Zhu
    Yongji Wang
    Scientific Reports, 15 (1)
  • [7] A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
    Sun, Rui
    Ning, Zhen
    Qin, Henan
    Zhang, Wenhe
    Teng, Yibin
    Jin, Chenxing
    Liu, Jiwei
    Wang, Aman
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Adverse events associated with potential drugs for COVID-19: a case study from real-world data
    Jing, Ying
    Diao, Lixia
    Han, Leng
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 1232 - 1238
  • [9] Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database
    Zou, Fan
    Cui, Zhiwei
    Lou, Siyu
    Ou, Yingyong
    Zhu, Chengyu
    Shu, Chengjie
    Chen, Junyou
    Zhao, Ruizhen
    Wu, Zhu
    Wang, Li
    Chen, Zhenyong
    Chen, Huayu
    Lan, Yuanbo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach
    Jung, Juhong
    Kim, Ju Hwan
    Bae, Ji-Hwan
    Woo, Simon S.
    Lee, Hyesung
    Shin, Ju-Young
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345